Showing results (111-120 of 335) with videos related to
Sort By:
Pageof 34
Metabolism: Clinical and Experimental|January 10, 2012
Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive proteinJames P Corsetti, Ron T Gansevoort, Stephan J L Bakker, et al.Journal of the American Society of Nephrology : JASN|May 24, 2014
Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participantsJames P Corsetti, Ron T Gansevoort, Stephan J L Bakker, et al.Journal of Internal Medicine|May 20, 2025
Higher circulating FGF21, lower protein intake, and lower muscle mass: Associations with a higher risk of mortalityAdrian Post, Wendy A Dam, Dion Groothof, et al.The Journal of Clinical Endocrinology and Metabolism|July 25, 2025
Thyroid function and all-cause mortality in the context of multimorbidity: results from two population-based studiesYanning Xu, Silvan Licher, W Edward Visser, et al.Journal of Clinical Lipidology|January 29, 2013
Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratioPaul J W H Kappelle, Ron T Gansevoort, Hans J Hillege, et al.European Journal of Internal Medicine|July 29, 2021
A metabolomic index based on lipoprotein subfractions and branched chain amino acids is associated with incident hypertensionJose L Flores-Guerrero, Margery A Connelly, Irina Shalaurova, et al.Primary Care Diabetes|May 11, 2024
Self-reported smoking, urine cotinine, and risk of type 2 diabetes: Findings from the PREVEND prospective cohort studySetor K Kunutsor, John Tetteh, Richard S Dey, et al.Atherosclerosis|April 18, 2013
Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitusMichela Triolo, Arjan J Kwakernaak, Frank G Perton, et al.Journal of Lipid Research|November 21, 2018
Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterolEline H van den Berg, Eke G Gruppen, Richard W James, et al.Clinical Endocrinology|January 3, 2013
Low normal free T4 confers decreased high-density lipoprotein antioxidative functionality in the context of hyperglycaemiaMichela Triolo, Jan Freark de Boer, Wijtske Annema, et al.Pageof 34